Top Stories

Curated By Isabella Tang

By Isabella Tang 2026-01-06

Investors Flock to Hong Kong's Biotech IPOs Amid Market Thaw

As the biotech sector in Hong Kong begins to recover, investors are increasingly turning their attention to initial public offerings (IPOs) in the industry. This trend signals renewed confidence in the market, highlighting the potential for growth in the region's biotech landscape.

By Isabella Tang 2026-01-06

Hong Kong Reclaims Top Global IPO Spot in 2025

Hong Kong has regained its status as the leading global destination for initial public offerings (IPOs) in 2025, according to a recent report by PwC. This resurgence reflects the city's robust financial market and investor confidence amidst a recovering global economy.

By Isabella Tang 2026-01-06

Chinese AI Firm MiniMax Set to Price Hong Kong IPO at Upper Range

Chinese artificial intelligence company MiniMax is expected to price its initial public offering (IPO) in Hong Kong at the top end of the anticipated range. This move highlights the growing interest in AI technology and the robust demand for tech stocks in the region.

By Isabella Tang 2026-01-06

HUTCHMED Advances Phase III Trial for Pancreatic Cancer Treatment

HUTCHMED has announced the initiation of a Phase III clinical trial for the combination therapy of Surufatinib and Camrelizumab aimed at treating pancreatic ductal adenocarcinoma. This trial represents a significant step forward in the fight against one of the most aggressive forms of cancer.